116 related articles for article (PubMed ID: 29742813)
1. Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis.
Zekeridou A; Griesmann GE; Lennon VA
Muscle Nerve; 2018 Oct; 58(4):600-604. PubMed ID: 29742813
[TBL] [Abstract][Full Text] [Related]
2. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
[TBL] [Abstract][Full Text] [Related]
3. Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.
Navaneetham D; Penn A; Howard J; Conti-Fine BM
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):433-42. PubMed ID: 9193799
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
[TBL] [Abstract][Full Text] [Related]
6. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
[TBL] [Abstract][Full Text] [Related]
7. Thymoma and paraneoplastic myasthenia gravis.
Marx A; Willcox N; Leite MI; Chuang WY; Schalke B; Nix W; Ströbel P
Autoimmunity; 2010 Aug; 43(5-6):413-27. PubMed ID: 20380583
[TBL] [Abstract][Full Text] [Related]
8. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy.
Vernino S; Hopkins S; Wang Z
Auton Neurosci; 2009 Mar; 146(1-2):3-7. PubMed ID: 18951069
[TBL] [Abstract][Full Text] [Related]
9. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
[TBL] [Abstract][Full Text] [Related]
10. Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia [correction of myastenia] gravis.
Gattenlöhner S; Brabletz T; Schultz A; Marx A; Müller-Hermelink HK; Kirchner T
Thymus; 1994; 23(2):103-13. PubMed ID: 7725386
[TBL] [Abstract][Full Text] [Related]
11. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
[TBL] [Abstract][Full Text] [Related]
12. Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.
Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7792-6. PubMed ID: 2145582
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
14. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
Infante AJ; Thompson PA; Krolick KA; Wall KA
J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
[TBL] [Abstract][Full Text] [Related]
15. Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.
Zekeridou A; Lennon VA
Mayo Clin Proc; 2019 Sep; 94(9):1865-1878. PubMed ID: 31358366
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
[TBL] [Abstract][Full Text] [Related]
17. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica).
Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H
Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743
[TBL] [Abstract][Full Text] [Related]
18. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
19. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes.
Vernino S; Adamski J; Kryzer TJ; Fealey RD; Lennon VA
Neurology; 1998 Jun; 50(6):1806-13. PubMed ID: 9633732
[TBL] [Abstract][Full Text] [Related]
20. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
